Display Settings:

Format

Send to:

Choose Destination
    Bioorg Med Chem Lett. 2008 Jan 15;18(2):694-9. Epub 2007 Nov 21.

    Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).

    Source

    Department of Discovery Chemistry and Discovery Biology, Bristol-Myers Squibb Research and Development, Route 206 and Province Line Road, Princeton, NJ 08543-4000, USA. gott@cephalon.com

    Abstract

    Selective inhibitors of TNF-alpha Converting Enzyme (TACE) based on (1R,2S)-cyclopentyl, (3S,4S)-pyrrolidinyl, and (3R,4S)-tetrahydrofuranyl beta-benzamido hydroxamic acids have been synthesized and evaluated. This study has led to the discovery of novel inhibitors whose profiles include activity against TACE in an enzyme assay, potency in the suppression of LPS-stimulated TNF-alpha in human whole blood, selectivity against a panel of MMPs and oral bioavailability.

    PMID:
    18061445
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk